AI
Thursday, February 04, 2010 11:27:47 AM
CRXX DD Post ($1.40). Looking for appreciation in price prior to FDA decision on Feb 22nd. If decision is positive I hope to see a strong appreciation in price w/ solid follow through due to share structure and no existing toxic debt.
~The company is debt-free
~18 Million in cash on hand
~ 18 mill/float...35 mill shares/OS....60 mill/Auth
~Deep pipeline.
~Partnership w/ Mallinckrodt (division of COV at $50/share-nasdaq)
Uncertainty for approval lies in whether the questions submitted by the FDA to CRXX were answered to satisfy all the requirements for approval. The FDA extended the deadline from 11/22 to 2/22 in mid-November. High risk/high reward potential.
A lot on the line w/ the possible approval of EXALGO in royalty fees and milestone payments.
investorshub.advfn.com/uimage/uploads/2010/2/4/zvkpwCRXX_top_institutional_holdings.JPG[/chart]
~The company is debt-free
~18 Million in cash on hand
~ 18 mill/float...35 mill shares/OS....60 mill/Auth
~Deep pipeline.
~Partnership w/ Mallinckrodt (division of COV at $50/share-nasdaq)
Uncertainty for approval lies in whether the questions submitted by the FDA to CRXX were answered to satisfy all the requirements for approval. The FDA extended the deadline from 11/22 to 2/22 in mid-November. High risk/high reward potential.
A lot on the line w/ the possible approval of EXALGO in royalty fees and milestone payments.
investorshub.advfn.com/uimage/uploads/2010/2/4/zvkpwCRXX_top_institutional_holdings.JPG[/chart]
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
